跳至主要内容
临床试验/DRKS00030368
DRKS00030368进行中(未招募)不适用

Clinical Performance Evaluation of MAGLUMI® SARS-CoV-2 Ag (CLIA) kit (for diagnostic of COVID-19) - REQA_22021_SNIB_CLA_COV

Shenzhen New Industries Biomedical Engineering Co., Ltd.0 个研究点目标入组 259 人开始时间: 2022年12月6日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
259

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Age: more than 18 years old; 2. Probands who agree to the utilization of their samples for processing, storage, analysis, documentation, optional shipment as required by the applied SARS-CoV-2 test and publication of study results in anonymized manner; 3. Subject must be experiencing at least one symptom of COVID-19 for 7 days or fewer from study enrolment.

排除标准

  • 1. less than 18 years old; 2. Vaccinated within the
  • last 48h; 3. Ear, nose and throat (ENT) operation within the last six months and/or encephalocele; 4. Haemophilia and/or using anticoagulant drugs; 5. Pregnant or breast-feeding; 6. Lack of compliance or other justifications that precludes satisfactory
  • participation in the study as judged by the investigator; 7. Inability to understand the nature of, extent of, and procedures required by the study as judged by the Investigator; 8. Being dependent of
  • the sponsor/investigator; 9. Not enough sample

研究者

相似试验

Clinical Performance Evaluation of MAGLUMI®... | 临床试验